Tracer library / [213Bi]Bi-2556

[213Bi]Bi-2556

Also written as [213Bi]Bi-2556
Radionuclide
Bi-213
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Preclinical only, no clinical indication yet

What it is

Compound class
Human monoclonal antibody
Target / mechanism
HIV-1 gp41 glycoprotein PMID 22427811
Clinical application
Elimination of HIV-1 infected cells for HIV eradication strategy PMID 22427811
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [213Bi]Bi-2556, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 3 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 22427811, 26595540, 27725930. Stage set/updated at stage 39 from PMID 22427811: 'We describe the preclinical development of a novel radiolabeled mAb reagent that could potentially be part of an HIV eradication strategy that is ready for translation into the clinic as the next step in its development.'.